Live tape
AgilentAgilent Technologies (A) Announces Retirement of Key Executive - GuruFocusFierceBiotechFDA’s Vinay Prasad to depart agency at the end of April10x Genomics BlogLife Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers - Yahoo Finance AustraliaBioPharma DiveVinay Prasad, controversial FDA leader, to again depart agencyThermo FisherPresident Donald Trump to visit Cincinnati to tout push for lower drug prices - WLWTEndpoints NewsVinay Prasad to exit FDA again, following latest round of controversyAgilentAgilent Technologies announces planned retirement of principal accounting officer - Investing.comWatersKevin Hern acquires Waters Corporation stock through Hern Family Revocable Trust - Investing.comLonza NewsLonza shakes off capsule business in $3B deal with Lone Star - Fierce PharmaFierceBiotechFDA to end 9-month advisory committee drought with April review of AstraZeneca’s oral SERD, TruqapEndpoints NewsLonza sells capsule and health ingredients unit for $2.2BLonza NewsLonza sells capsule and health ingredients unit to UK's Lone Star for $2.2B - Endpoints News
Endpoints News Dec 26, 2025

Biohaven’s ion channel drug fails again, this time in major depressive disorder

Biohaven’s ion channel drug fails again, this time in major depressive disorder

Open original source
Full body text is not stored for this item yet. Use the original source to continue reading.
Directory ribbon

Brand directory, kept in view

A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.

Open about page